Advertisement
For hospitalized patients

Daily INR Measurement Best for Hospitalized Patients on Warfarin

0
Increased odds of warfarin-associated adverse events in patients for whom INR not measured daily
Daylight photodynamic therapy with a novel variant of unsaturated ALA ester

Daylight Photodynamic Therapy Effective, Safe for Acne

0
PDT with 1.5 percent 3-butenyl 5-aminolevulinate gel reduces inflammatory, non-inflammatory lesions
A single infusion of the potent human monoclonal antibody targeting the HIV-1 CD4 binding site

Infusion of HIV-Neutralizing Antibody Decreases Viremia

0
Strong selection pressure seen for outgrowth of less neutralization-sensitive viruses
For patients with active ankylosing spondylitis

Secukinumab Cuts Symptoms of Ankylosing Spondylitis

0
Two trials show benefits for 150 mg subcutaneous secukinumab with IV, subcutaneous loading
For patients with pulmonary arterial hypertension

Selexipag Linked to Reduced Risk of Death, Complications in PAH

0
Reduced risk of composite of death or pulmonary arterial hypertension-linked complications
Zurampic (lesinurad) has been approved by the U.S. Food and Drug Administration to control blood levels of uric acid associated with gout.

FDA Approves Zurampic for the Treatment of Gout

0
Drug helps control blood levels of uric acid
A minority of patients discharged with chronic obstructive pulmonary disease receive pharmacologic treatment for tobacco use

Few Get Rx to Help Quit Smoking After COPD Hospitalization

0
Treatment not associated with cessation at six to 12 months; differences between medications
The U.S. Preventive Services Task Force (USPSTF) has found that current evidence is insufficient for determining the balance of benefits and harms of lipid disorder screening in children

Two Draft Statements From USPSTF Open for Comment

0
Insufficient evidence for lipid screening in children; recommendation for statins varies with age, risk
Men who have sex with men who have abstained from sex for one year will now be allowed to donate blood in the United States. The new policy

FDA Lifts Ban on Blood Donations by Men Who Have Sex With Men

0
National blood surveillance system will help agency ensure safety of the blood supply
Uptravi (selexipag) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension.

FDA Approves Uptravi for Pulmonary Arterial Hypertension

0
Drug found to limit worsening of the disease and reduce the need for hospitalization